Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingye Wu

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Cancer Letters|January 24, 2013
Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: effects associated with STAT3/SurvivinKunming Wen, Zhongxue Fu, Xingye Wu, et al.
Bioscience Reports|April 23, 2017
Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathwayJun Xu, Shouru Zhang, Rong Wang, et al.
Translational Cancer Research|February 4, 2022
ANXA3 is upregulated by hypoxia-inducible factor 1-alpha and promotes colon cancer growthKunli Du, Jiahui Ren, Zhongxue Fu, et al.
Frontiers in Oncology|May 13, 2026
The effect of adjuvant imatinib treatment for patients with high-risk gastrointestinal stromal tumorJie Zhang, Donghui Gao, Hongming Cui, et al.
Journal of Gastrointestinal Oncology|May 17, 2024
Contribution of genetic polymorphism in <i>ABCB1</i> to individual variations of imatinib plasma levels in patients with gastrointestinal stromal tumorYinggang Ge, Huili Bai, Alessandro Mazzocca, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 29, 2015
Inhibition of phospholipaseD2 increases hypoxia-induced human colon cancer cell apoptosis through inactivating of the PI3K/AKT signaling pathwayMaoxi Liu, Zhongxue Fu, Xingye Wu, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 20, 2024
Correlation Between Thyroid Hormone and Controlled Attenuation Parameters: A Cross-Sectional Population-Based StudySumei Li, Xingye Wu, Jingming Yu, et al.
Translational Cancer Research|July 15, 2022
Expression of HIF-1α, ANXA3, CD133 and their associations with clinicopathological parameters in human colon carcinomaXiaoyan Chai, Xiao Wu, Jiahui Ren, et al.
Frontiers in Nutrition|April 28, 2022
Comparison of the Suitability Between NRS2002 and MUST as the First-Step Screening Tool for GLIM Criteria in Hospitalized Patients With GISTXin Zhou, Junjin Liu, Qijuan Zhang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 13, 2025
Correlation Between the Controlled Attenuation Parameter and the Prevalence of T2DM in Southern China: A Retrospective Cross-Sectional StudyXingye Wu, Ruibing Qi, Jiaqin Jiang, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Cancer Letters|January 24, 2013
Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: effects associated with STAT3/SurvivinKunming Wen, Zhongxue Fu, Xingye Wu, et al.
Bioscience Reports|April 23, 2017
Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathwayJun Xu, Shouru Zhang, Rong Wang, et al.
Translational Cancer Research|February 4, 2022
ANXA3 is upregulated by hypoxia-inducible factor 1-alpha and promotes colon cancer growthKunli Du, Jiahui Ren, Zhongxue Fu, et al.
Frontiers in Oncology|May 13, 2026
The effect of adjuvant imatinib treatment for patients with high-risk gastrointestinal stromal tumorJie Zhang, Donghui Gao, Hongming Cui, et al.
Journal of Gastrointestinal Oncology|May 17, 2024
Contribution of genetic polymorphism in <i>ABCB1</i> to individual variations of imatinib plasma levels in patients with gastrointestinal stromal tumorYinggang Ge, Huili Bai, Alessandro Mazzocca, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 29, 2015
Inhibition of phospholipaseD2 increases hypoxia-induced human colon cancer cell apoptosis through inactivating of the PI3K/AKT signaling pathwayMaoxi Liu, Zhongxue Fu, Xingye Wu, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 20, 2024
Correlation Between Thyroid Hormone and Controlled Attenuation Parameters: A Cross-Sectional Population-Based StudySumei Li, Xingye Wu, Jingming Yu, et al.
Translational Cancer Research|July 15, 2022
Expression of HIF-1α, ANXA3, CD133 and their associations with clinicopathological parameters in human colon carcinomaXiaoyan Chai, Xiao Wu, Jiahui Ren, et al.
Frontiers in Nutrition|April 28, 2022
Comparison of the Suitability Between NRS2002 and MUST as the First-Step Screening Tool for GLIM Criteria in Hospitalized Patients With GISTXin Zhou, Junjin Liu, Qijuan Zhang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 13, 2025
Correlation Between the Controlled Attenuation Parameter and the Prevalence of T2DM in Southern China: A Retrospective Cross-Sectional StudyXingye Wu, Ruibing Qi, Jiaqin Jiang, et al.
Pageof 8